Patients risks

Assess patient risk factors for osteoporosis, with special attention to age, menopausal status, previous history of osteoporotic fracture, smoking status, low body weight, family history of osteoporotic fracture in first-degree relatives, and presence of secondary causes of osteoporosis. 

Evaluate patient risk factors and recent exposures. 

Empirical antibiotic selection for acute bacterial rhinosinusitis should incorporate patient risk factors for bacterial resistance. 

Assess patient risk factors prior to onset of treatment. 

Initiate pharmacotherapy for non-ST-segment elevation ACS based upon patient risk evaluate moderate and high-risk patients for early angiography and revascularization... 

EPS, extra pyramidal side effects. Relative side-effect risk , negligible +, low ++, moderate +++, moderately high ++++, high. °Side effects shown are relative risk based on doses within the recommended therapeutic range, individual patient risk varies depending on patient-specific factors. 

Abstract Quality of care is complicated, especially in the elderly. For a start we need drugs with evidence for the benefits and risks in the elderly, this is currently not always the case. Thereafter we need to use the drugs in an evidence based way, which may be difficult in the complex health care system. To achieve maximum benefit for the patient (outcome) and society (health-economy) a well planned process is needed. This includes identification, prevention and resolving of the patients drug-related problems decisions and selection of treatment, communication and decisions together with the patient, risk minimisation, and communication within health care. Several of these aspects are presented in this chapter. 

At the same time, several types of data necessary to ensure proper management of occupational risks associated with a drug substance are not generally useful in evaluating potential patient risks. So the necessary tests—eye and skin irritation, sensitization and inhalation toxicity, as well as assessment of the hazards of byproducts and impurities that do not get incorporated into the final therapeutic product—are not performed in the normal course of development. 

TABLE 21.3. Factors that Increase Patient Risk for Adverse Drug Interactions... 

Bates, D.W., Miller, E.B., Cullen, D.J., Burdiek, L., Williams, L., and Laird, N., Patient risk faetors for adverse drug events in hospitalized patients, zlrcA Intern. Med., 159 2553-2560 (1999). 

Imipenem-cilastatin is one of the drugs of first choice for the empirical therapy of many polymicrobial pulmonary, intraabdominal, and soft tissue infections. The notable adverse effect of imipenem-cilastatin is seizures affecting 1% of patients. Risk factors for seizures are old age, head trauma, previous seizure disorder, cerebrovascular accident, and renal failure. Among patients with a history of penicillin allergy, 10% are cross-sensitive to imipenem-cilastatin. 

In completely resected chemonaive NSCLC patients, risk of relapse increased as ERCCl mRNA levels decreased (53). The same investigators found that low RRMl levels in resectable NSCLC patients significantly increased the risk of relapse (54). These important clinical observations establish the bases for customizing adjuvant treatment in early NSCLC. Patients whose tumors have low NER gene expression have a higher risk of relapse and can be exquisitely sensitive to combinations such as... 

Subjective (e.g., Epworth Sleepiness Scale) and objective [e.g., Multiple Sleep Latency Test (MSLT)] daytime somnolence quantification does not seem to provide valuable information on patients risks. This could be explained by the fact that sleep-related accidents occur at certain times when behavioral and chronobiological factors play an important role. Medical and legal issues could nevertheless require an objective test, such as the Maintenance of Wakefulness Test (MWT), to confirm that treated apneic patients present a normal level of vigilance. 

Parker JB. The effects of fatigue on physician performance—an underestimated cause of physician impairment and increased patient risk. Can J Anaesth 1987 34 489 195. 

Establish the context. What are the goals of the risk management process What are potential vulnerabilities of the business Do employees or patients risk injuries How might the reputation of the pharmacy suffer if a patient was injured owing to a prescription error or if his or her health condition was inadvertently made public by an employee Could costly claims be avoided by not providing certain services or products ... 

B5. Barrans, S. L., Carter, I., Owen, R. G., Davies, F. E., Patmore, R. D., Haynes, A. P., Morgan, G. L, and Jack, A. S., Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood 99,1136-1143 (2002). 

Individual patient risk varies depending on patient-specific factors. 

Care based on regular comprehensive care guidelines based on all individual patient risk factors. 

Regular interval comprehensive examinations depending on individual patient risk factors. Cataracts have not been shown to form in normal therapeutic doses. 

---